Diagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: A Review and Summary of Current Literature

Lung cancer is the leading cause of cancer related morbidity and mortality worldwide. Currently, the vast majority of lung cancers are diagnosed at a late stage, when patients become symptomatic leading to dismal, less than 15% five-year survival rates. Evidence has demonstrated that screening compu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gyoba, Jennifer, Shan, Shubham, Roa, Wilson, Bédard, Eric L. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848950/
https://www.ncbi.nlm.nih.gov/pubmed/27043555
http://dx.doi.org/10.3390/ijms17040494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848950/
https://www.ncbi.nlm.nih.gov/pubmed/27043555
http://dx.doi.org/10.3390/ijms17040494

Ejemplares similares